Literature DB >> 32885398

Where the Other Half Dies: Analysis of Mortalities Occurring More Than 30 Days After Complex Cancer Surgery.

Benjamin J Resio1, Lou Gonsalves2, Maureen Canavan3, Lloyd Mueller2, Cathryn Phillips2, Tejas Sathe4, Katrina Swett2, Daniel J Boffa5.   

Abstract

BACKGROUND: Nearly half of operative mortalities occur outside the traditionally studied 30-day period after surgery. To identify additional opportunities to improve surgical safety, the circumstances of deaths occurring 31-90 days after complex cancer surgery are analyzed. PATIENTS AND METHODS: Patients aged ≥ 65 years who died within 90 days of complex cancer surgery for nonmetastatic cancer were analyzed in the Surveillance, Epidemiology, and End Results (SEER)-Medicare and the Connecticut Tumor Registry (CTR) databases.
RESULTS: Of the 36,114 patients undergoing complex cancer surgery from 2004 to 2013 in SEER-Medicare, 1367 (3.8%) died within 31-90 days ("late mortalities"). Seventy-eight percent of late mortalities were readmitted prior to death. The highest proportion of late mortalities occurred during a readmission (49%), and 11% were never discharged from their index admission. Cause of death (COD) was largely attributed to the malignancy itself (56%), which is unlikely to be the underlying cause. Of the noncancer COD, cardiac causes were most frequent (34%), followed by pulmonary causes (18%). Death was rarely attributed to thromboembolic disease (< 1%). The CTR provided location of death, which was most commonly in a hospital (65%) or nursing facility (20%); death at home was rare (6%).
CONCLUSIONS: The vast majority of patients dying between 31 and 90 days of surgery were admitted to a hospital or nursing facility at the time of their death after initially being discharged, and few patients died at home. Greater clarity in death documentation is needed to identify specific opportunities to rescue patients from fatal complications arising in the later postoperative period.

Entities:  

Mesh:

Year:  2020        PMID: 32885398     DOI: 10.1245/s10434-020-09080-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  18 in total

1.  Use of national surgical quality improvement program data as a catalyst for quality improvement.

Authors:  Katherine S Rowell; Florence E Turrentine; Matthew M Hutter; Shukri F Khuri; William G Henderson
Journal:  J Am Coll Surg       Date:  2007-06       Impact factor: 6.113

2.  Relationship of processes and structures of care in general surgery to postoperative outcomes: a descriptive analysis.

Authors:  Deborah S Main; William G Henderson; Katherine Pratte; Tia A Cavender; Tracy L Schifftner; Anne Kinney; Tamara Stoner; John F Steiner; Aaron S Fink; Shukri F Khuri
Journal:  J Am Coll Surg       Date:  2007-06       Impact factor: 6.113

3.  Association of Frailty With Failure to Rescue After Low-Risk and High-Risk Inpatient Surgery.

Authors:  Rupen Shah; Kristopher Attwood; Shipra Arya; Daniel E Hall; Jason M Johanning; Emmanuel Gabriel; Anthony Visioni; Steven Nurkin; Moshim Kukar; Steven Hochwald; Nader N Massarweh
Journal:  JAMA Surg       Date:  2018-05-16       Impact factor: 14.766

4.  Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality.

Authors:  Yoshihiro Mise; Jean-Nicolas Vauthey; Giuseppe Zimmitti; Nathan H Parker; Claudius Conrad; Thomas A Aloia; Jeffrey E Lee; Jason B Fleming; Matthew Harold G Katz
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

5.  Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy.

Authors:  David Yu Greenblatt; Kaitlyn J Kelly; Victoria Rajamanickam; Yin Wan; Todd Hanson; Robert Rettammel; Emily R Winslow; Clifford S Cho; Sharon M Weber
Journal:  Ann Surg Oncol       Date:  2011-02-20       Impact factor: 5.344

6.  Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis.

Authors:  Ryan P Merkow; Karl Y Bilimoria; Martin D McCarter; Mark E Cohen; Carlton C Barnett; Mehul V Raval; Joseph A Caprini; Howard S Gordon; Clifford Y Ko; David J Bentrem
Journal:  Ann Surg       Date:  2011-07       Impact factor: 12.969

7.  Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond.

Authors:  Robert A Hiatt; Caroline G Tai; Douglas W Blayney; Dennis Deapen; Michael Hogarth; Kenneth W Kizer; Joseph Lipscomb; Jennifer Malin; Stephen K Phillips; John Santa; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2015-03-11       Impact factor: 13.506

8.  Surgical site infection prevention: the importance of operative duration and blood transfusion--results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative.

Authors:  Darrell A Campbell; William G Henderson; Michael J Englesbe; Bruce L Hall; Michael O'Reilly; Dale Bratzler; E Patchen Dellinger; Leigh Neumayer; Barbara L Bass; Matthew M Hutter; James Schwartz; Clifford Ko; Kamal Itani; Steven M Steinberg; Allan Siperstein; Robert G Sawyer; Douglas J Turner; Shukri F Khuri
Journal:  J Am Coll Surg       Date:  2008-10-10       Impact factor: 6.113

9.  Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program.

Authors:  Justin B Dimick; Steven L Chen; Paul A Taheri; William G Henderson; Shukri F Khuri; Darrell A Campbell
Journal:  J Am Coll Surg       Date:  2004-10       Impact factor: 6.113

10.  Risk factors for adverse outcomes after transurethral resection of bladder tumors.

Authors:  Brent K Hollenbeck; David C Miller; David Taub; Rodney L Dunn; Shukri F Khuri; William G Henderson; James E Montie; Willie Underwood; John T Wei
Journal:  Cancer       Date:  2006-04-01       Impact factor: 6.860

View more
  2 in total

1.  Comprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer.

Authors:  Shenghan Lou; Jian Zhang; Xin Yin; Yao Zhang; Tianyi Fang; Yimin Wang; Yingwei Xue
Journal:  Front Cell Dev Biol       Date:  2022-01-10

2.  Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer.

Authors:  Shenghan Lou; Yufei Wang; Jian Zhang; Xin Yin; Yao Zhang; Yimin Wang; Yingwei Xue
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.